Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
For providers, having a potent oral option improves long-term adherence for patients who are averse to subcutaneous injections
Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use
There are a couple of things you can do to improve the longevity of your results, in fact, we made a video about it
Long-term data beyond 12 weeks in humans does not exist from controlled trials
Deficiency can cause numbness, tingling, and cognitive fog
This includes everything from daily injections at first to monthly doses later on
US$ 29.01
US$ 23.92
US$ 27.26
US$ 29.37
